title: Adjuvant treatment of advanced-stage endometrial cancer.
abstract: Despite the overall favorable prognosis for women with endometrial cancer, those with advanced and metastatic disease are at significant risk of major morbidity and death. Traditional treatment for advanced-stage endometrial cancer has relied on radiation. The last decade has witnessed a dramatic shift in treatment paradigms for women with advanced-stage endometrial cancer. Chemotherapy is now the cornerstone of treatment for most women with stages III and IV disease. Ongoing trials are exploring multimodal therapy incorporating both chemotherapy and radiation as well as novel chemotherapeutic, biologic and hormonal agents for both advanced primary and recurrent disease. In this review, we discuss the treatment of women with advanced-stage metastatic or recurrent endometrial cancer.
authors.affiliation: University of Chicago Medical Center, Chicago, Illinois, USA. nlee@babies.bsd.uchicago.edu
authors.forename: Nita Karnik
authors.initials: NK
authors.lastname: Lee
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D002296:Carcinosarcoma / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D016889:Endometrial Neoplasms / Q000473:pathology* / Q000628:therapy*; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D018714:Radiotherapy, Adjuvant